SPAC959.05c Antibody

What is SPAC959.05c Antibody and what are its key characteristics?

SPAC959.05c Antibody is a polyclonal antibody raised in rabbits against the recombinant Schizosaccharomyces pombe (strain 972 / ATCC 24843) SPAC959.05c protein . This antibody specifically recognizes the SPAC959.05c protein (UniProt ID: Q9P4X1) from fission yeast. The antibody is purified using antigen affinity methods and is provided in liquid form with a storage buffer containing 0.03% Proclin 300 as a preservative, 50% glycerol, and 0.01M PBS at pH 7.4 .

As a polyclonal antibody, it recognizes multiple epitopes on the target protein, which can be advantageous for detection applications but requires careful validation to ensure specificity in your experimental system. The antibody has been tested for application in ELISA and Western blotting techniques .

What are the recommended storage conditions and handling protocols for SPAC959.05c Antibody?

For optimal performance and stability of SPAC959.05c Antibody:

• Store the antibody at -20°C or -80°C immediately upon receipt

• Avoid repeated freeze-thaw cycles, as this can lead to antibody degradation and loss of activity

• When handling, keep the antibody on ice and return to storage promptly after use

• Consider aliquoting the antibody into single-use volumes upon first thaw to minimize freeze-thaw cycles

• Prior to use, allow the antibody to equilibrate to room temperature and mix gently by inversion, avoiding vigorous shaking or vortexing

Proper storage and handling are critical for maintaining antibody functionality, as improper protocols can significantly affect antibody performance and experimental reproducibility .

What validation methods should be applied to verify SPAC959.05c Antibody performance?

Comprehensive validation of SPAC959.05c Antibody is essential for reliable research outcomes. Based on current antibody validation standards, consider the following approaches:

• Genetic validation: Test antibody reactivity in wild-type vs. SPAC959.05c knockout S. pombe strains to demonstrate specificity

• Orthogonal detection: Compare SPAC959.05c protein levels detected by the antibody with levels determined by an antibody-independent method (e.g., mass spectrometry)

• Multiple antibody verification: If available, compare results with another antibody targeting a different epitope of SPAC959.05c

• Recombinant expression: Test with overexpressed SPAC959.05c protein to confirm detection capability

The "five pillars" approach to antibody validation includes the methods above and has become an increasingly accepted standard in the research community . Researchers should document and report validation methods in publications to enhance reproducibility .

What controls should be included when using SPAC959.05c Antibody in experiments?

Proper controls are critical for interpreting results with SPAC959.05c Antibody:

Including these controls with proper documentation enhances experimental rigor and reproducibility, addressing known issues in antibody-based research .

How can cross-reactivity of SPAC959.05c Antibody be assessed in complex experimental systems?

Cross-reactivity assessment is essential, especially for polyclonal antibodies like SPAC959.05c Antibody. Implement these advanced approaches:

• Immunoprecipitation followed by mass spectrometry (IP-MS): This method can definitively identify all proteins captured by the antibody

  • Protocol: Perform standard IP with SPAC959.05c Antibody

  • Process captured proteins for MS analysis

  • Compare identified proteins to expected target

• Competition assays: Use purified recombinant SPAC959.05c protein to compete for antibody binding

  • Pre-incubate antibody with increasing concentrations of purified target

  • Observe diminished signal with increasing competitor concentration

  • Persistent signals may indicate cross-reactivity

• Orthogonal validation across applications: If the antibody detects multiple bands/signals in one application (e.g., Western blot), verify whether these same targets appear in other applications (e.g., immunofluorescence)

Cross-reactivity profiles can vary between applications due to differences in protein conformation, epitope accessibility, and detection sensitivity. Document all observed cross-reactivity to inform experimental design and data interpretation .

What methodologies can optimize SPAC959.05c Antibody performance in Western blotting applications?

Optimizing Western blot protocols for SPAC959.05c Antibody requires systematic evaluation:

• Sample preparation optimization:

  • Test multiple lysis buffers to ensure complete solubilization

  • Compare denaturing conditions (reducing vs. non-reducing)

  • Evaluate different sample heating protocols (70°C vs. 95°C)

• Antibody titration matrix:

  • Create a concentration gradient (typically 1:500 to 1:5000)

  • Test against different protein loads (5-50μg)

  • Identify optimal signal-to-noise ratio conditions

• Blocking optimization:

  • Compare BSA vs. non-fat dry milk as blocking agents

  • Test different blocking buffer concentrations (1-5%)

  • Evaluate blocking time (1 hour vs. overnight)

• Signal development strategies:

  • Compare chemiluminescent vs. fluorescent detection methods

  • For quantitative analysis, use fluorescent secondary antibodies

  • Establish linear detection range for quantification

Document optimal conditions in a detailed protocol to ensure reproducibility across experiments . Consider developing a standardized operating procedure specific to SPAC959.05c detection.

How can epitope mapping inform experimental design when using SPAC959.05c Antibody?

Understanding the epitopes recognized by SPAC959.05c Antibody can significantly enhance experimental design:

• Computational epitope prediction:

  • Use structure prediction tools like AlphaFold2 to model SPAC959.05c protein

  • Apply epitope prediction algorithms to identify likely antibody binding regions

  • Molecular docking software can predict antibody-antigen interactions

• Experimental epitope mapping:

  • Peptide array analysis using overlapping peptides spanning SPAC959.05c

  • Mutagenesis of predicted epitope regions to confirm binding sites

  • Hydrogen/deuterium exchange mass spectrometry to identify binding interfaces

• Application implications:

  • If epitopes are located in structured domains, native conditions may be required

  • Epitopes in flexible regions may be more accessible in denatured conditions

  • Multiple epitope recognition (as in polyclonal antibodies) provides robustness but potential cross-reactivity

Knowledge of epitope locations can help determine if the antibody will be suitable for detecting protein complexes, post-translational modifications, or protein fragments .

What strategies should be employed when integrating SPAC959.05c Antibody data with other -omics approaches?

Integration of antibody-based detection with multi-omics data requires careful consideration:

• Correlation with transcriptomic data:

  • Compare protein levels detected by SPAC959.05c Antibody with mRNA expression

  • Discrepancies may indicate post-transcriptional regulation

  • Establish statistical methods for correlation analysis

• Integration with proteomics data:

  • Use mass spectrometry-based quantification as orthogonal validation

  • Compare protein abundance ratios between methods

  • Document methodological differences affecting quantification

• Pathway and network analysis:

  • Map SPAC959.05c to known interaction networks in S. pombe

  • Use antibody-based co-immunoprecipitation to validate predicted interactions

  • Integrate with genetic interaction data for functional insights

• Data normalization considerations:

  • Develop normalization strategies across different data types

  • Account for dynamic range differences between methods

  • Implement appropriate statistical corrections for multiple comparisons

Multi-omics integration enhances the biological context of SPAC959.05c studies beyond what single-method approaches can achieve .

How can SPAC959.05c Antibody be applied in advanced microscopy techniques?

While SPAC959.05c Antibody is primarily validated for ELISA and Western blotting , researchers may adapt it for advanced microscopy with appropriate optimization:

• Super-resolution microscopy optimization:

  • Test fixation methods (paraformaldehyde, methanol, acetone) for epitope preservation

  • Evaluate permeabilization conditions (Triton X-100, saponin, digitonin)

  • Determine optimal antibody concentration through titration experiments

  • Use fluorophore-conjugated secondary antibodies with appropriate spectral properties

• Live-cell imaging considerations:

  • If attempting intracellular delivery, evaluate antibody fragmentation options (Fab, scFv)

  • Test membrane permeabilization techniques compatible with cell viability

  • Consider genetic approaches (fluorescent protein fusions) as alternatives

• Colocalization studies:

  • Select markers for cellular compartments relevant to SPAC959.05c function

  • Implement appropriate controls for spectral bleed-through

  • Use quantitative colocalization analysis (Pearson's, Manders' coefficients)

• Validation criteria:

  • Compare localization patterns with GFP-tagged SPAC959.05c

  • Verify specificity using SPAC959.05c deletion strains

  • Document all optimization steps for reproducibility

Advanced microscopy may require additional validation beyond the manufacturer's recommended applications .

What approaches can identify potential post-translational modifications of SPAC959.05c using antibody-based methods?

Investigating post-translational modifications (PTMs) requires specialized approaches:

• PTM-specific antibody complementation:

  • Use general PTM antibodies (phospho-Ser/Thr/Tyr, acetyl-Lys, etc.) in conjunction with SPAC959.05c immunoprecipitation

  • Perform sequential immunoprecipitation with SPAC959.05c Antibody followed by PTM-specific antibodies

• Modification-sensitive detection:

  • Compare migration patterns with and without phosphatase/deacetylase treatment

  • Use Phos-tag™ acrylamide gels to enhance phosphorylation-dependent mobility shifts

  • Apply 2D-gel electrophoresis to separate protein isoforms

• Mass spectrometry integration:

  • Immunoprecipitate SPAC959.05c using the antibody

  • Process for LC-MS/MS analysis with PTM-specific search parameters

  • Validate identified modification sites through mutagenesis studies

• Functional correlation:

  • Map modification sites to protein domains and structural features

  • Correlate modification status with cellular conditions and stress responses

  • Develop hypotheses about regulatory mechanisms based on modification patterns

Antibody-based PTM identification should be validated with orthogonal approaches due to potential epitope masking by modifications .